Somatostatin in renal physiology and autosomal dominant polycystic kidney disease

Abstract Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation, leading to growth in kidney volume and renal function decline. Although therapies have emerged, there is still an important unmet need for slowing the rate of disease progression in ADPKD. H...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nephrology, dialysis, transplantation dialysis, transplantation, 2020-08, Vol.35 (8), p.1306-1316
Hauptverfasser:	Messchendorp, A Lianne, Casteleijn, Niek F, Meijer, Esther, Gansevoort, Ron T
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Disease Progression Hormones - therapeutic use Humans Kidney - drug effects Kidney - physiology Polycystic Kidney, Autosomal Dominant - drug therapy Reviews Somatostatin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!